back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-06-05 Tx date 2018-06-04 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,000
-5,000 vol $8.00 each |
2,356,557 | |
| Filed 2018-06-05 Tx date 2018-06-04 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,200
-5,000 vol $8.04 each |
2,361,557 | |
| Filed 2018-06-05 Tx date 2018-06-04 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-93,264
-11,600 vol $8.04 each |
3,054,097 | |
| Filed 2018-06-05 Tx date 2018-06-04 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-48,120
-6,000 vol $8.02 each |
3,065,697 | |
| Filed 2018-06-04 Tx date 2018-05-31 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,200
-5,000 vol $8.04 each |
3,080,097 | |
| Filed 2018-06-04 Tx date 2018-06-01 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,984
-4,600 vol $8.04 each |
3,071,697 | |
| Filed 2018-06-04 Tx date 2018-05-31 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,818
-3,800 vol $8.11 each |
3,076,297 | |
| Filed 2018-06-01 Tx date 2018-05-31 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,135
-4,500 vol $8.03 each |
2,367,057 | |
| Filed 2018-06-01 Tx date 2018-05-31 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,020
-500 vol $8.04 each |
2,366,557 | |
| Filed 2018-06-01 Tx date 2018-05-30 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-72,180
-9,000 vol $8.02 each |
3,085,097 | |
| Filed 2018-06-01 Tx date 2018-05-30 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,600
-5,000 vol $8.12 each |
3,094,097 | |
| Filed 2018-05-31 Tx date 2018-05-25 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,430
-10,000 vol $8.14 each |
||
| Filed 2018-05-31 Tx date 2018-05-24 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,650
-5,000 vol $8.13 each |
2,406,557 | |
| Filed 2018-05-31 Tx date 2018-05-24 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,550
-10,000 vol $8.15 each |
||
| Filed 2018-05-31 Tx date 2018-05-24 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,900
-5,000 vol $8.18 each |
2,411,557 | |
| Filed 2018-05-31 Tx date 2018-05-30 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-101,430
-12,600 vol $8.05 each |
2,371,557 | |
| Filed 2018-05-31 Tx date 2018-05-28 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,632
-2,400 vol $8.18 each |
2,389,157 | |
| Filed 2018-05-31 Tx date 2018-05-28 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,120
-1,000 vol $8.12 each |
2,391,557 | |
| Filed 2018-05-31 Tx date 2018-05-28 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,628
-200 vol $8.14 each |
2,392,557 | |
| Filed 2018-05-31 Tx date 2018-05-28 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,970
-3,800 vol $8.15 each |
2,392,757 | |
| Filed 2018-05-31 Tx date 2018-05-28 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-60,347
-7,400 vol $8.15 each |
||
| Filed 2018-05-31 Tx date 2018-05-25 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,086
-2,600 vol $8.11 each |
2,396,557 | |
| Filed 2018-05-31 Tx date 2018-05-25 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,180
-1,500 vol $8.12 each |
2,399,157 | |
| Filed 2018-05-31 Tx date 2018-05-25 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,317
-900 vol $8.13 each |
2,400,657 | |
| Filed 2018-05-31 Tx date 2018-05-25 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,850
-5,000 vol $8.17 each |
2,401,557 | |
| Filed 2018-05-30 Tx date 2018-05-29 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,500
-5,000 vol $8.10 each |
2,384,157 | |
| Filed 2018-05-29 Tx date 2018-05-28 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-60,347
-7,400 vol $8.15 each |
2,389,157 | |
| Filed 2018-05-28 Tx date 2018-05-25 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,430
-10,000 vol $8.14 each |
2,396,557 | |
| Filed 2018-05-28 Tx date 2018-05-24 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,550
-10,000 vol $8.15 each |
2,406,557 | |
| Filed 2018-05-24 Tx date 2018-05-23 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-63,911
-7,900 vol $8.09 each |
2,416,557 | |
| Filed 2018-05-24 Tx date 2018-05-23 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,550
-5,000 vol $8.11 each |
2,424,457 | |
| Filed 2018-05-23 Tx date 2018-05-22 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,250
-5,000 vol $8.05 each |
2,431,557 | |
| Filed 2018-05-23 Tx date 2018-05-22 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,094
-2,100 vol $8.14 each |
2,429,457 | |
| Filed 2018-05-22 Tx date 2018-05-17 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,628
-700 vol $8.04 each |
2,439,357 | |
| Filed 2018-05-22 Tx date 2018-05-17 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,928
-1,600 vol $8.08 each |
2,436,557 | |
| Filed 2018-05-22 Tx date 2018-05-17 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-807.00
-100 vol $8.07 each |
2,438,157 | |
| Filed 2018-05-22 Tx date 2018-05-17 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,224
-400 vol $8.06 each |
2,438,257 | |
| Filed 2018-05-22 Tx date 2018-05-17 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,635
-700 vol $8.05 each |
2,438,657 | |
| Filed 2018-05-22 Tx date 2018-05-17 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,045
-1,500 vol $8.03 each |
2,440,057 | |
| Filed 2018-05-17 Tx date 2018-05-16 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-80,000
-10,000 vol $8.00 each |
2,441,557 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-62,634
-7,800 vol $8.03 each |
2,451,557 | |
| Filed 2017-04-12 Tx date 2017-02-27 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Options
52 - Expiration of options
|
-278,000 vol |
0 | |
| Filed 2017-04-12 Tx date 2017-02-27 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-222,000 vol |
0 | |
| Filed 2017-04-06 Tx date 2017-04-03 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-52,050
-5,000 vol $10.41 each |
2,459,357 | |
| Filed 2017-04-06 Tx date 2017-04-03 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-33,440
-3,200 vol $10.45 each |
2,464,357 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$1,152,309
+139,000 vol $8.29 each |
3,099,097 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$920,189
+111,000 vol $8.29 each |
2,467,557 | |
| Filed 2015-09-11 Tx date 2015-09-09 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,356,557 | ||
| Filed 2015-09-11 Tx date 2015-09-09 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2015-09-11 Tx date 2015-09-09 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,960,097 | ||
| Filed 2015-09-11 Tx date 2015-09-09 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Medison Biotech (1995) Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,014,230 |